急诊医疗补助项目或可为创伤患者提供持续保险:一项全州纵向分析
该研究利用加州卫生保健服务部定制的HPE获批患者纵向理赔数据集,分析2016年和2017年HPE获批的成人主要创伤诊断患者,主要结局为6个月时Medicaid保险维持情况,并进行单因素和多因素分析。共纳入9749例HPE创伤患者,6795例(69.7%)在6个月时维持了Medicaid保险。维持保险者中ISS>15者占73.5%(未维持者68.7%,p<0.001)、接受手术者占74.8%(未维持者64.5%,p<0.001)、出院转至急性后期服务机构者占23.9%(未维持者10.4%,p<0.001)。调整分析中,严重损伤(ISS>16,对比ISS<15:aOR 1.51;p=0.02)和手术(aOR 1.85;p<0.001)与维持保险可能性增加相关;拒绝披露种族、民族或语言者(aOR 0.05;p<0.001)维持保险可能性降低。作者认为HPE项目是为创伤患者获得长期保险覆盖的有前景途径,尤其对可能需要持续获得医疗服务资源的严重创伤患者。
要点
- 在9749例HPE获批的成人创伤患者中,6795例(69.7%)在伤后6个月维持了Medicaid保险。
- 维持保险者ISS>15比例高于未维持者(73.5% vs. 68.7%,p<0.001),接受手术比例也更高(74.8% vs. 64.5%,p<0.001)。
- 维持保险者出院转至急性后期服务机构比例为23.9%,未维持者为10.4%(p<0.001)。
- 调整分析显示,严重损伤(ISS>16,对比ISS<15:aOR 1.51;p=0.02)和手术(aOR 1.85;p<0.001)与维持保险可能性增加相关。
- 拒绝披露种族、民族或语言者(aOR 0.05;p<0.001)维持保险的可能性降低;该组2505例(25.7%)中维持率仅14.8%。
适用人群与场景
- 2016年和2017年在加州HPE获批的成人主要创伤诊断(国际疾病分类第10版)患者,共9749例。
研究设计与关键结果
- 研究类型为利用加州卫生保健服务部定制纵向理赔数据集的分析;纳入2016年和2017年HPE获批的成人主要创伤诊断患者9749例;主要结局为6个月时Medicaid保险维持情况。
- 6个月时维持Medicaid保险者6795例(69.7%)。
- 维持保险者与未维持者比较:ISS>15比例为73.5% vs. 68.7%(p<0.001);接受手术比例为74.8% vs. 64.5%(p<0.001);出院转至急性后期服务机构比例为23.9% vs. 10.4%(p<0.001)。
- 按自我报告的种族分类,Medicaid保险维持率分别为:白人86.7%、西班牙裔86.7%、黑人84.3%、亚裔83.7%。
- 拒绝报告种族、民族或首选语言者2505例(25.7%),其维持率为14.8%。
- 调整分析:严重损伤(ISS>16,对比ISS<15)与维持保险可能性增加相关(aOR 1.51;p=0.02);手术与维持保险可能性增加相关(aOR 1.85;p<0.001);拒绝披露种族、民族或语言与维持保险可能性降低相关(aOR 0.05;p<0.001)。
证据类型、等级与局限
- 证据类型:预后与流行病学研究;证据水平:Level IV。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,医院推定资格(HPE)项目是为创伤患者获得长期保险覆盖的有前景途径,尤其对可能需要持续获得医疗服务资源的严重创伤患者。
- 作者认为,对患者和提供者进行访谈有助于阐明患者未能维持保险的障碍。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Hospital Presumptive Eligibility (HPE) is a temporary Medicaid insurance at hospitalization that offsets costs of care, increases access to postdischarge resources, and provides patients with a path to sustain coverage through Medicaid. Because HPE only lasts up to 60 days, we aimed to determine Medicaid insurance status 6 months after injury among HPE-approved trauma patients and identify factors associated with successful sustainment.
METHODS: Using a customized longitudinal claims data set for HPE-approved patients from the California Department of Health Care Services, we analyzed adults with a primary trauma diagnosis (International Classification of Diseases version 10) who were HPE approved in 2016 and 2017. Our primary outcome was Medicaid sustainment at 6 months. Univariate and multivariate analyses were performed.
RESULTS: A total of 9,749 trauma patients with HPE were analyzed; 6,795 (69.7%) sustained Medicaid at 6 months. Compared with patients who did not sustain, those who sustained had higher Injury Severity Score (ISS > 15: 73.5% vs. 68.7%, p < 0.001), more frequent surgical intervention (74.8% vs. 64.5%, p < 0.001), and were more likely to be discharged to postacute services (23.9% vs. 10.4%, p < 0.001). Medicaid sustainment was high among patients who identified as White (86.7%), Hispanic (86.7%), Black (84.3%), and Asian (83.7%). Medicaid sustainment was low among the 2,505 patients (25.7%) who declined to report race, ethnicity, or preferred language (14.8% sustainment). In adjusted analyses, major injuries (ISS > 16) (vs. ISS < 15: adjusted odds ratio [aOR], 1.51; p = 0.02) and surgery (aOR, 1.85; p < 0.001) were associated with increased likelihood of Medicaid sustainment. Declining to disclose race, ethnicity, or language (aOR, 0.05; p < 0.001) decreased the likelihood of Medicaid sustainment.
CONCLUSION: Hospital Presumptive Eligibility programs are a promising pathway for securing long-term insurance coverage for trauma patients, particularly among the severely injured who likely require ongoing access to health care services. Patient and provider interviews would help to elucidate barriers for patients who do not sustain.
LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level IV.
参考来源
- Knowlton LM, Tran LD, Arnow K, et al. Emergency Medicaid programs may be an effective means of providing sustained insurance among trauma patients: A statewide longitudinal analysis. J Trauma Acute Care Surg. 2022. PMID: 36138539. doi:10.1097/TA.0000000000003796
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。